Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen: Did Nancy Pelosi Buy Shares Last Week?
08:08am, Monday, 17'th Oct 2022
In my opinion, Pelosi's buy is a rumor, but at least an interesting coincidence. Either way, Amgen is currently fairly valued and investors can expect solid, though slow, returns.
Amgen (AMGN) Stock Moves -0.13%: What You Should Know
09:50pm, Friday, 14'th Oct 2022 Zacks Investment Research
Amgen (AMGN) closed the most recent trading day at $251.34, moving -0.13% from the previous trading session.
What Happened This Week: Index Swings, Grocery Giants And Short Records
08:37pm, Friday, 14'th Oct 2022 Investing.com
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
05:52pm, Friday, 14'th Oct 2022 Benzinga
BMO Capital Markets raised the price target on Replimune Group Inc (NASDAQ: REPL) to $40 from $30 on a bullish view into upcoming data readouts for lead asset RP1 in melanoma and cutaneous squam
Amgen: As A Defensive Play?
06:30am, Friday, 14'th Oct 2022
The 10-year treasury can be a benchmark that investors consider when weighing positions in dividend yielding stocks. What is the current fundamental outlook for AMGN?
Amgen Shares Leap Higher On Upbeat Outlook For Obesity Treatment
09:20am, Thursday, 13'th Oct 2022
Shares of Amgen soared 5.72% Tuesday and added to those gains Wednesday. The gap-up followed a Morgan Stanley upgrade and increase to the price target.
What 6 Analyst Ratings Have To Say About Amgen
06:19pm, Wednesday, 12'th Oct 2022 Benzinga
Over the past 3 months, 6 analysts have published their opinion on Amgen (NASDAQ:AMGN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's
Strength Seen in Amgen (AMGN): Can Its 5.7% Jump Turn into More Strength?
03:07pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Amgen (AMGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
Amgen (AMGN) Recently Broke Out Above the 50-Day Moving Average
01:30pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
Amgen (AMGN) Crossed Above the 200-Day Moving Average: What That Means for Investors
01:30pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
01:00pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Stock Market News for Oct 12, 2022
01:00pm, Wednesday, 12'th Oct 2022 Zacks Investment Research
Wall Street closed mixed on Tuesday after a choppy session.
Strength Seen in Amgen (AMGN): Can Its 5.7% Jump Turn into More Strength?
12:47pm, Wednesday, 12'th Oct 2022
Amgen (AMGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
The Zacks Analyst Blog Highlights Chevron, Amgen, HSBC, CVS Health and S&P Global
10:44am, Wednesday, 12'th Oct 2022 Zacks Investment Research
Chevron, Amgen, HSBC, CVS Health and S&P Global are included in this Analyst Blog.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:32am, Wednesday, 12'th Oct 2022
Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
